To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Feature Video
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Felicia Mitchell
Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.
Sagar Lonial, M.D.
Here is what one expert says about the right time to start treating relapsed multiple myeloma.
This hike marks the fifth continent to be visited by a Moving Mountains for Multiple Myeloma team
Katie Kosko
Five leading cancer organizations came together to establish four steps that patients of all malignancies can turn to as they navigate their experience.
Kristie L. Kahl
We spoke with two members of the Moving Mountains for Multiple Myeloma team.
Brielle Urciuoli
Dewayne Johnson is the first of hundreds of patients to take Monsanto to trial, claiming that Roundup caused them to get cancer. His case will be seen even sooner than others because in California dying plaintiffs can be given expedited trials.
Brielle Urciuoli
The Food and Drug Administration (FDA) approved the supplemental New Drug Application to add to the U.S. Prescribing Information for Kyprolis (carfilzomib) for the treatment of patients with relapsed or refractory multiple myeloma.
Katie Kosko
Cancer affects many aspects of a person’s life, such as the overall quality of their day-to-day living, but what if a person didn’t have the full-blown disease already? Could a precursor or asymptomatic stage of the disease still burden them?

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other